|
Gadolinium Clinical Trials
5 actively recruiting trials across 4 locations
No change since May 2026
Also known as: Gadavist, Gd
Pipeline
Phase 1: 2Phase 2: 2
Top Sponsors
- Wake Forest University Health Sciences1
- University of Texas Southwestern Medical Center1
- Sunnybrook Health Sciences Centre1
- OHSU Knight Cancer Institute1
- M.D. Anderson Cancer Center1
Indications
- Cancer4
- Hypertrophy1
- Acute Promyelocytic Leukemia With PML-RARA1
- Heart Disease1
- Cranial Nerve Disorder1
Other1 trial
Winston-Salem, North Carolina1 trial
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Wake Forest Baptist Comprehensive Cancer Center
Phase 2
Portland, Oregon1 trial
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
OHSU Knight Cancer Institute
Phase 2
Dallas, Texas1 trial
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
UT Southwestern Medical Center
Houston, Texas1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.